Inventor profile of:

Arne Dessen

City:

Royken

Country:

Norway

Published Applications:

16

Last publication date:

2023-05-04

Top Assignees for applications by Arne Dessen

The entities that hold a legal rights for patent applications filed by inventor Dessen Arne:

Recent patent applications by Dessen Arne

Arne Dessen from Royken, NO has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-05-04
US20230139922A1
Human necessities

BACITRACIN-ALGINATE OLIGOMER CONJUGATES

#2 | 2022-09-29
US20220305050A1
Human necessities

USE OF ALGINATE OLIGOMERS IN THE ANTICOAGULATION THERAPY OF SUBJECTS AT RISK OF BLOOD CLOTS WHICH HAVE AN ABNORMALLY DENSE MICROSTRUCTURE

#3 | 2022-03-10
US20220074853A1
Physics

Method for the qualitative and quantitative detection of alginate oligomers in body fluids

#4 | 2021-12-16
US20210386666A1
Human necessities

Inhalable powder formulations of alginate oligomers

#5 | 2021-02-04
US20210030891A1
Human necessities

USE OF ALGINATE OLIGOMERS TO ENHANCE THE TRANSLOCATION OF MICRO/NANOPARTICLES ACROSS MUCUS LAYERS

#6 | 2019-11-28
US20190360925A1
Physics

A COMPANION DIAGNOSTIC METHOD FOR USE IN THE TREATMENT OF CYSTIC FIBROSIS WITH ALGINATE OLIGOMERS

#7 | 2019-10-31
US20190328833A1
Human necessities

POLYMYXIN-ALGINATE OLIGOMER CONJUGATES

#8 | 2019-04-25
US20190117683A1
Human necessities

Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract

#9 | 2018-08-23
US20180235879A1
Human necessities

INHALABLE POWDER FORMULATIONS OF ALGINATE OLIGOMERS

#10 | 2018-03-01
US20180055873A1
Human necessities

Use of aliginate oligomers and CFTR modulators in treatment of conditions associated with CFTR dysfunction

#11 | 2016-12-15
US20160361342A1
Human necessities

USE OF ALGINATE OLIGOMERS IN THE TREATMENT OF CYSTIC FIBROSIS AND OTHER CONDITIONS ASSOCIATED WITH DEFECTIVE CFTR ION CHANNEL FUNCTION

#12 | 2016-11-17
US20160331777A1
Human necessities

Use of alginate oligomers as blood anticoagulants

#13 | 2015-05-07
US20150126467A1
Human necessities

USE OF ALGINATE OLIGOMERS TO ENHANCE THE EFFECTS OF ANTIFUNGAL AGENTS

#14 | 2011-02-24
US20110046085A1
Human necessities

Oral Immunostimulation of Fish from (1-4) Linked Beta-D-Mannuronic Acid

#15 | 2005-04-14
US20050080036A1
Human necessities

Oral immunostimulation of mammals birds and reptiles from (1-4) linked β-D-mannuronic acid

#16 | 2005-02-03
US20050026865A1
Human necessities

Oral immunostimulation of fish from (1-4) linked β-D-mannuronic acid

InventorID:

1153222 ⎘